About cimdr:

Cimdr was founded by China food and drug International Exchange Center (ccfdie) in 2010. The purpose of the meeting is to strengthen the publicity of China's medical device regulatory laws and policies, promote the experience exchange and cooperation between international medical device regulatory and evaluation departments, standardize the business order of enterprises, promote the exchange between enterprises and governments, and promote the application of new technical standards and technological achievements, so as to further improve the safety and effectiveness of medical devices. After 11 years of development, "cimdr" has developed from the initial "meeting of 100 people" to today's "meeting of 1000 people", becoming a unique conference in the industry.

The 11th China International Conference on the supervision and administration of medical devices will be held in Fuzhou, Fujian Province from November 18 to 20, 2020.

Among them, "the 11th cimdr medical device post marketing verification and risk management branch" will start at 08:30 on November 19, 2020. This branch has invited the food and drug audit and inspection center of the State Drug Administration, the Department of medical device supervision and administration of the State Drug Administration, the drug evaluation center of the State Drug Administration, as well as general electric, Roche Experts from BD and other international well-known medical device manufacturers in the United States made a detailed interpretation of the relevant contents of post marketing verification and risk management of medical devices.

Mr. Fu Hongtao, general manager of Shenzhen Zhuoyuan Tiancheng Consulting Co., Ltd., as a senior regulatory expert of medical devices, is invited to participate in this forum and deliver a keynote speech of "FDA 510 (k) review without change". We sincerely invite you to participate!

Contents of the meeting: